https://www.selleckchem.com/pr....oducts/chir-99021-ct
Currently, in North America we are fortunate to have a number of available options for lipid emulsions to be used in the parenteral nutrition regimens for infants and children, including for long term parenteral nutrition given intestinal failure. Neonates and infants in particular are at risk for intestinal failure associated liver disease (IFALD). The choice of parenteral lipid emulsion will influence the risk and severity of IFALD. The purpose of this review is to discuss the rationale for the composite lipid emulsion
Like
Comment
Share
